S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
S&P 500   3,941.26 (-1.44%)
DOW   33,596.34 (-1.03%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
TSE:CRON

Cronos Group - CRON Stock Forecast, Price & News

C$4.11
-0.63 (-13.29%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
C$4.11
C$4.74
50-Day Range
C$3.71
C$4.74
52-Week Range
C$3.32
C$5.98
Volume
496,383 shs
Average Volume
341,626 shs
Market Capitalization
C$1.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$4.75
CRON stock logo

About Cronos Group (TSE:CRON) Stock

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

Cannabis Stock Movers For November 16, 2022
Top Cannabis Stocks
Can Cronos Group Q3 results bring positive surprise?
Cronos Group Inc. Announces Final Settlement Agreements
CRON Cronos Group Inc.
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Company Calendar

Today
12/06/2022
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$4.75
High Stock Price Forecast
C$7.00
Low Stock Price Forecast
C$3.00
Forecasted Upside/Downside
+15.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$94.81 million
Cash Flow
C$2.07 per share
Book Value
C$3.16 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.56 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Michael Ryan Gorenstein J.D. (Age 35)
    Pres, CEO & Chairman
    Comp: $389.15k
  • Ms. Shannon Buggy (Age 52)
    Sr. VP & Global Head of People
    Comp: $438.81k
  • Ms. Anna Shlimak (Age 36)
    Sr. VP of Corp. Affairs & Strategy
    Comp: $422.03k
  • Mr. James Holm
    Chief Financial Officer
  • Mr. Carlos Cortez (Age 49)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 32)
    Sr. VP of Legal & Regulatory Affairs and Corp. Sec.
  • Mr. Jeffrey David Jacobson (Age 36)
    Chief Growth Officer
  • Mr. Arye Weigensberg
    Head of R&D
  • Mr. Kevin B Gifford
    VP of Fin.













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2023?

6 equities research analysts have issued 12-month target prices for Cronos Group's shares. Their CRON share price forecasts range from C$3.00 to C$7.00. On average, they expect the company's stock price to reach C$4.75 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2022?

Cronos Group's stock was trading at C$4.98 at the beginning of 2022. Since then, CRON shares have decreased by 4.8% and is now trading at C$4.74.
View the best growth stocks for 2022 here
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our CRON earnings forecast
.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$4.74.

How much money does Cronos Group make?

Cronos Group (TSE:CRON) has a market capitalization of C$1.79 billion and generates C$94.81 million in revenue each year.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is Suite 300, Toronto, Ontario M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at 416-504-0004.

This page (TSE:CRON) was last updated on 12/6/2022 by MarketBeat.com Staff